CLINICAL TRIALS PROFILE FOR TECHNETIUM TC-99M MEBROFENIN KIT
✉ Email this page to a colleague
All Clinical Trials for technetium tc-99m mebrofenin kit
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00767468 ↗ | Sorafenib in Treating Patients With Locally Advanced or Metastatic Liver Cancer and Cirrhosis | Terminated | National Cancer Institute (NCI) | Phase 1 | 2008-10-01 | RATIONALE: Sorafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor. PURPOSE: This phase I trial is studying the side effects and best dose of sorafenib in treating patients with locally advanced or metastatic liver cancer and cirrhosis. |
NCT00767468 ↗ | Sorafenib in Treating Patients With Locally Advanced or Metastatic Liver Cancer and Cirrhosis | Terminated | UNC Lineberger Comprehensive Cancer Center | Phase 1 | 2008-10-01 | RATIONALE: Sorafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor. PURPOSE: This phase I trial is studying the side effects and best dose of sorafenib in treating patients with locally advanced or metastatic liver cancer and cirrhosis. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for technetium tc-99m mebrofenin kit
Condition Name
Clinical Trial Locations for technetium tc-99m mebrofenin kit
Trials by Country
Clinical Trial Progress for technetium tc-99m mebrofenin kit
Clinical Trial Phase
Clinical Trial Sponsors for technetium tc-99m mebrofenin kit
Sponsor Name